General Information of MET (ID: META00378) |
Name |
5-Aminolevulinic acid
|
Synonyms |
Click to Show/Hide Synonyms of This Metabolite
5 Aminolaevulinate; 5 Aminolevulinate; 5-ALA; 5-Amino-4-oxo-pentanoate; 5-Amino-4-oxo-pentanoic acid; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovalerate; 5-Amino-4-oxovaleric acid; 5-Amino-levulinate; 5-Amino-levulinic acid; 5-Aminolaevulinate; 5-Aminolaevulinic acid; 5-Aminolevulinate; Acid hydrochloride, aminolevulinic; Acid, Delta-aminolevulinic; Acid, aminolevulinic; Aladerm; Amino-levulinic acid; Aminolevulinic acid; Aminolevulinic acid hydrochloride; Bertek brand OF aminolevulinic acid hydrochloride; DALA; Delta Aminolevulinic acid; Hydrochloride, aminolevulinic acid; Kerastick; Levulan; delta-ALA; delta-Aminolevulinic acid
|
Source |
Endogenous;Escherichia Coli Metabolite;Yeast Metabolite;Fatty acyls;Food;Drug;Toxins/Pollutant;Microbial
|
Structure Type |
Amino acids, peptides, and analogues (Click to Show/Hide the Complete Structure Type Hierarchy)
Organic acids and derivatives
Carboxylic acids and derivatives
Amino acids, peptides, and analogues
|
PubChem CID |
|
HMDB ID |
|
Formula |
C5H9NO3
|
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=137"></iframe>
|
 |
3D MOL
|
2D MOL
|
|
Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
|
KEGG ID |
|
DrugBank ID |
|
ChEBI ID |
|
FooDB ID |
|
ChemSpider ID |
|
METLIN ID |
|
Physicochemical Properties |
Molecular Weight |
131.13 |
Topological Polar Surface Area |
80.4 |
XlogP |
-3.8 |
Complexity |
121 |
Heavy Atom Count |
9 |
Rotatable Bond Count |
4 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
4 |
Function |
5-Aminolevulinic acid is an intermediate in heme synthesis. This is the first compound in the porphyrin synthesis pathway. It is produced by the enzyme ALA synthase, from glycine and succinyl CoA. This reaction is known as the Shemin pathway. Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
|
Regulatory Network
|
|
|
|
|
|
|
|